Cite
Carter P, Alifrangis C, Cereser B, et al. Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy. Oncotarget. 2017;9(5):6007-6014doi: 10.18632/oncotarget.23675.
Carter, P., Alifrangis, C., Cereser, B., Chandrasinghe, P., Del Bel Belluz, L., Fotopoulou, C., Frilling, A., Herzog, T., Moderau, N., Tabassum, N., Krell, J., & Stebbing, J. (2018). Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy. Oncotarget, 9(5), 6007-6014. https://doi.org/10.18632/oncotarget.23675
Carter, Philip, et al. "Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy." Oncotarget vol. 9,5 (2018): 6007-6014. doi: https://doi.org/10.18632/oncotarget.23675
Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Del Bel Belluz L, Fotopoulou C, Frilling A, Herzog T, Moderau N, Tabassum N, Krell J, Stebbing J. Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy. Oncotarget. 2017 Dec 27;9(5):6007-6014. doi: 10.18632/oncotarget.23675. eCollection 2018 Jan 19. PMID: 29464050; PMCID: PMC5814190.
Copy
Download .nbib